ARM vs GSK

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 14, 2026

ARM

53.5
AI Score
VS
GSK Wins

GSK

54.0
AI Score

Investment Advisor Scores

ARM

54score
Recommendation
HOLD

GSK

54score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ARM GSK Winner
Forward P/E 147.0588 22.1239 GSK
PEG Ratio 2.6678 19.9224 ARM
Revenue Growth 20.1% 1.5% ARM
Earnings Growth 47.9% 8.4% ARM
Tradestie Score 53.5/100 54.0/100 GSK
Profit Margin 18.4% 17.8% ARM
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Frequently Asked Questions

Based on our detailed analysis, GSK is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.